−6.80TWD
−688.02 MTWD
90.00 KTWD
About BRIM BIOTECHNOLOGY INC
Sector
Industry
CEO
Hai Shan Jian
Website
Headquarters
Taipei
Employees (FY)
24
Founded
2013
ISIN
TW0006885007
FIGI
BBG0184QQTZ9
BRIM Biotechnology, Inc. engages in the research and development of treatment drugs. It offers medicines for dry eye syndrome, corneal damage repair, neurotrophic keratitis, and osteoarthritis. The company was founded by Hai Shan Jian and Wen Chi Lee on July 31, 2013 and is headquartered in Taipei, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 6885 is 32.45 TWD — it has decreased by 2.84% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange BRIM BIOTECHNOLOGY INC stocks are traded under the ticker 6885.
6885 stock is 4.80% volatile and has beta coefficient of 1.12. Check out the list of the most volatile stocks — is BRIM BIOTECHNOLOGY INC there?
Yes, you can track BRIM BIOTECHNOLOGY INC financials in yearly and quarterly reports right on TradingView.
6885 stock has risen by 5.70% compared to the previous week, the month change is a 3.71% fall, over the last year BRIM BIOTECHNOLOGY INC has showed a 55.61% decrease.
6885 net income for the last quarter is −527.71 M TWD, while the quarter before that showed −160.31 M TWD of net income which accounts for −229.18% change. Track more BRIM BIOTECHNOLOGY INC financial stats to get the full picture.
No, 6885 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6885 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BRIM BIOTECHNOLOGY INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 28, 2024, the company has 24.00 employees. See our rating of the largest employees — is BRIM BIOTECHNOLOGY INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BRIM BIOTECHNOLOGY INC technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BRIM BIOTECHNOLOGY INC stock shows the sell signal. See more of BRIM BIOTECHNOLOGY INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BRIM BIOTECHNOLOGY INC EBITDA is −688.72 M TWD, and current EBITDA margin is −765.24 K%. See more stats in BRIM BIOTECHNOLOGY INC financial statements.